Ray Dalio Atrion Corp Transaction History

Bridgewater Associates, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$308.3 - $463.55 $67,209 - $101,053	-218 Reduced 14.9%	1,245 $577,000
Q4 2023 Feb 14, 2024	SELL	$289.29 - $409.7 $50,047 - $70,878	-173 Reduced 10.57%	1,463 $554,000
Q3 2023 Nov 13, 2023	BUY	$401.2 - $581.79 $58,174 - $84,359	145 Added 9.73%	1,636 $675,000
Q2 2023 Aug 11, 2023	SELL	$500.0 - $659.0 $78,500 - $103,463	-157 Reduced 9.53%	1,491 $843,000
Q1 2023 May 12, 2023	BUY	$565.0 - $694.87 $25,990 - $31,964	46 Added 2.87%	1,648 $1.03 Million
Q4 2022 Feb 13, 2023	SELL	$551.1 - $688.5 $311,922 - $389,691	-566 Reduced 26.11%	1,602 $896,000
Q3 2022 Nov 10, 2022	SELL	$545.43 - $680.3 $8,181 - $10,204	-15 Reduced 0.69%	2,168 $1.23 Million
Q2 2022 Aug 11, 2022	BUY	$605.0 - $763.25 $119,790 - $151,123	198 Added 9.97%	2,183 $1.37 Million
Q1 2022 May 13, 2022	BUY	$601.4 - $763.0 $264,616 - $335,720	440 Added 28.48%	1,985 $1.42 Million
Q4 2021 Feb 14, 2022	SELL	$650.15 - $802.0 $182,042 - $224,560	-280 Reduced 15.34%	1,545 $1.09 Million
Q3 2021 Nov 12, 2021	SELL	$594.24 - $758.0 $45,162 - $57,608	-76 Reduced 4.0%	1,825 $1.27 Million
Q2 2021 Aug 13, 2021	BUY	$582.88 - $670.99 $1.11 Million - $1.28 Million	1,901 New	1,901 $1.18 Million

114K

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.